About Mogad Solidarity

We are establishing the MOGAD Solidarity Foundation with the responsibility of ensuring that individuals living with MOG Antibody-Associated Disease (MOGAD) know they are not alone, and of standing by them in every aspect as they fight this illness. 

Our mission goes beyond raising awareness.
We are here to provide comprehensive support, from diagnosis to treatment, from emotional care to social visibility.

Because we believe:
No matter how rare the disease, no one should have to face it in silence.

Every Drop of Help Builds
a Better Tomorrow

Donate Now

Spectrum: MOGAD

MOGAD is a disease spectrum that presents with different symptoms and signs in every patient. It may cause vision loss, cognitive changes, pain, or movement difficulties. It can be confused with conditions like encephalitis, transverse myelitis, or NMO. 

In some cases, these conditions may appear together. Diagnosis is often complex, and each patient’s journey is unique. That’s why awareness and accurate information are crucial. 

MOGAD may be invisible — but its impact reaches every corner of life. This platform exists to raise visibility, share knowledge, and empower those affected.

https://www.youtube.com/watch?v=pfox5lJQNkw&t=1s

MOGAD: What Happens When the Immune System Attacks the Brain?

https://www.youtube.com/watch?v=quCMQkf3z6oUnderstanding Pain in MOGAD: Demyelination and Its Effects on the Bodyhttps://www.youtube.com/watch?v=MNnnxvc-pQI

Trapped in the Loop: Understanding Psychological Symptoms in MOGAD

https://www.youtube.com/watch?v=DWUk4l8xgKIMedications and Supplements for the Neuropsychological Impact of MOGAD

Our Core Principles

“MOGAD Solidarity aims to raise awareness of MOGAD, educating the public and healthcare professionals about this rare neurological disease.”
“Our goal is to provide guidance, resources, and support to patients and families affected by MOGAD, ensuring they are not alone on their journey.”
“We strive to promote research, collect knowledge, and educate healthcare professionals to improve understanding and care for MOGAD patients.”